兰索拉唑
DNA合成
西咪替丁
雷尼替丁
奥美拉唑
法莫替丁
药理学
受体
化学
表皮生长因子
肝细胞
体外
内分泌学
内科学
生物化学
生物
医学
作者
Pierre Blanc,Jacques Liautard,Jölle Greuet,Jean Pierre Daurès,Jean‐Michel Fabre,Dominique Larrey,Henri Michel,Patrick Maurel
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:1995-09-01
卷期号:22 (3): 814-819
标识
DOI:10.1002/hep.1840220319
摘要
The aim of this work was to investigate the effect of four H2 receptor antagonists, cimetidine, ranitidine, famotidine, nizatidine, and of two proton pump inhibitors, omeprazole and lansoprazole, on the mitotic response of human hepatocytes in primary culture. After plating at subconfluent density, cells were exposed to 0.2 to 20 μmol/L of these drugs for 48 hours, either in the absence or in the presence of epidermal growth factor (EGF). The rate of DNA synthesis was evaluated by [ 3 H]-thymidine incorporation into genomic DNA. Both the basal rate of DNA synthesis and the extent of stimulation by EGF exhibited a wide interindividual variability, and were not correlated with the viability of freshly prepared cells. In contrast, the effects of anti-ulcer drugs on the rate of DNA synthesis were clearly reproducible from one culture to another. H2 receptor antagonists had no significant effect ( P > .3) over the entire range of concentration tested, whereas omeprazole and lansoprazole significantly inhibited the rate of DNA synthesis by 60% to 90% at 20 μmol/L ( P = .016). This effect was concentration dependent between 2 and 20 μmol/L. Neither of the drugs tested was cytotoxic under the conditions used in this work, as assessed by measurements of the de novo protein synthesis. We conclude that, in contrast to H2 receptor antagonists, omeprazole and lansoprazole are able to interfere with the replicative synthesis of DNA in human hepatocytes in culture, at suprapharmacological concentrations. Whether or not this effect is clinically significant remains to be established. (Hepatology 1995; 22:814-819.)
科研通智能强力驱动
Strongly Powered by AbleSci AI